NCT03874390

Brief Summary

The objective of this study is to evaluate of ozone therapy on both clinical and biochemical effects in periodontally patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 1, 2016

Completed
2.9 years until next milestone

First Posted

Study publicly available on registry

March 14, 2019

Completed
Last Updated

March 15, 2019

Status Verified

March 1, 2019

Enrollment Period

1 year

First QC Date

May 1, 2016

Last Update Submit

March 13, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • Clinical atachment level baseline

    Calculation as distance in millimeters from cement-enamel junction to the bottom of the pocket by Williams periodontal probe

    baseline (before treatment)

  • Plaque index baseline

    As described by Silness\&Löe 1964; The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3. Scores 0: No plaque. scores 1: A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface. scores 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye. scores 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin. score 0 considered good oral hygiene, score 3 bad oral hygiene habits. plaque index for a tooth=scores from 4 areas/4 plaque index individiual= scores from 28 tooth/28

    baseline (before treatment)

  • Gingival index baseline

    As described by Löe\&Silness 1963; The bleeding is assessed by probing gently along the wall of soft tissue of the gingival sulcus. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3. score 0 - Normal, healthy gingival with sharp, non-inflamed margins. score 1 - Marginal gingivitis with minimal inflammation and edema at the free gingival. No bleeding on probing. score 2 - Moderate gingivitis with a wider band of inflammation and bleeding upon probing. score 3 - Advanced gingivitis with inflammation clinically reaching the mucogingival junction usually with ulceration. score 0 considered healty gingiva, score 3 assesed advanced gingival disease. gingival index for a tooth=scores from 4 areas/4 gingival index individiual= scores from 28 tooth/28

    baseline (before treatment)

  • Bleeding on probing baseline

    As described by Ainamo\&Bay 1975; The index is performed through gentle probing of the orifice of the gingival crevice. If bleeding occurs within 10 seconds a positive finding is recorded and the number of positive sites is recorded and then expressed as a percentage of the number of sites examined. bleeding present (+) absent (-) bleeding surface/all surface \*100=% bleeding absent recording is equivalent to gingival index scores 0\&1. bleeding present recording is equivalent to gingival index score 2\&3. * 0: no bleeding on probing, healty gingiva * 100: all gingiva bleeding on probing; diseased gingiva.

    baseline (before treatment)

  • Probing of depth baseline

    Measurement to the nearest millimeter from the gingival margin to the base of the clinical pocket by Williams periodontal probe

    baseline (before treatment)

  • Biochemical outcomes baseline

    In this study, biochemical parametres including IL-1B, IL-6, IL-10, TNF-a, MMP-9 were measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) methods on Gingival Crevicular Fluid at baseline.

    baseline (before treatment)

Secondary Outcomes (6)

  • Clinical attachment level after 8 weeks

    8 weeks after treatment

  • Plaque index after 8 weeks

    8 weeks after treatment

  • Gingival index after 8 weeks

    8 weeks after tretament

  • Bleeding on probing after 8 weeks

    8 weeks after treatment

  • Probing of dept after 8 weeks

    8 weeks after tretament

  • +1 more secondary outcomes

Study Arms (2)

ozone therapy

EXPERIMENTAL

control group only treated with Initial Periodontal Therapy (IPT), test group treated with IPT an adjunct to gasesos ozone therapy.

Other: ozone

initially periodontal therapy

ACTIVE COMPARATOR

control group only treated with Initial Periodontal Therapy (IPT), test group treated with IPT an adjunct to gasesos ozone therapy.

Other: ozone

Interventions

ozoneOTHER

gaseous ozone was applied on periodontal pocket two times in one week.

initially periodontal therapyozone therapy

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • systemically healthy
  • non-smokers
  • chronic periodontitis participants

You may not qualify if:

  • smokers
  • pregnancy or lactation
  • individiuals with any systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Ozone

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OxygenGasesInorganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

May 1, 2016

First Posted

March 14, 2019

Study Start

October 1, 2014

Primary Completion

October 1, 2015

Study Completion

February 1, 2016

Last Updated

March 15, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share